Baiyunshan Receives SSE Approval for Guangzhou Pharmaceutical Receivables ABS Listing

Stock News
03/16

Baiyushan PH (00874) announced that on March 13, 2026, the company received a no-objection letter from the Shanghai Stock Exchange (SSE) forwarded by Industrial Securities Asset Management Co., Ltd. The letter confirms that the asset-backed securities for the Xingzheng Yuanrong-Guangzhou Pharmaceutical Receivables Phases 5-9 Special Asset-Backed Plan meet the SSE's listing requirements, and the exchange has no objection to their listing and transfer. The asset-backed securities will be issued in multiple tranches, adopting a non-renewable issuance structure, with a total issuance amount not exceeding RMB 3 billion. The first tranche must be completed within 12 months from the date of the no-objection letter. The letter remains valid for 24 months from its issuance date.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10